2 ml tirzepatide vial 159.00 | --- 36 mg / --- 2 ml --- Weight Loss Glucagon-Like Peptide-1 (GLP-1) Doesn't seem to be enough

The most commonly discussed side effects are typically gastrointestinal, including nausea, vomiting, diarrhea, constipation, and reduced appetite

My doctor noted the benefits to inflammation and we went over possible side effects

10.1016/j.physbeh.2018.12.002 95 FeterN.SchaunG

Unfortunately, new reports show an increased risk of gastrointestinal conditions like stomach paralysis (gastroparesis), intestinal paralysis (paralytic ileus) or a rare disorder causing vision loss

The medication became available by prescription in early January 2026, offering a non-injectable alternative to the weekly Wegovy injection

The perception of obesity as a lack of willpower has long been a barrier to effective treatment